325 related articles for article (PubMed ID: 22382314)
1. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines.
Ikehata M; Ueda K; Iwakawa S
Biol Pharm Bull; 2012; 35(3):301-7. PubMed ID: 22382314
[TBL] [Abstract][Full Text] [Related]
2. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
3. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
4. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF
PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
[TBL] [Abstract][Full Text] [Related]
6. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy.
Lee TB; Park JH; Min YD; Kim KJ; Choi CH
BMC Gastroenterol; 2008 Aug; 8():33. PubMed ID: 18673531
[TBL] [Abstract][Full Text] [Related]
8. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells.
Meng CF; Su B; Li W
Mol Med Rep; 2011; 4(6):1273-8. PubMed ID: 21850374
[TBL] [Abstract][Full Text] [Related]
9. Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells.
Ikehata M; Ogawa M; Yamada Y; Tanaka S; Ueda K; Iwakawa S
Biol Pharm Bull; 2014; 37(1):67-73. PubMed ID: 24172061
[TBL] [Abstract][Full Text] [Related]
10. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells.
Liu Z; Marquez M; Nilsson S; Holmberg AR
Oncol Rep; 2008 Jul; 20(1):151-4. PubMed ID: 18575731
[TBL] [Abstract][Full Text] [Related]
11. Identification of epigenetically silenced genes in tumor endothelial cells.
Hellebrekers DM; Melotte V; Viré E; Langenkamp E; Molema G; Fuks F; Herman JG; Van Criekinge W; Griffioen AW; van Engeland M
Cancer Res; 2007 May; 67(9):4138-48. PubMed ID: 17483324
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
Meng F; Sun G; Zhong M; Yu Y; Brewer MA
Int J Oncol; 2013 Aug; 43(2):495-502. PubMed ID: 23709006
[TBL] [Abstract][Full Text] [Related]
13. Promoter CpG methylation in cancer cells contributes to the regulation of MUC4.
Yamada N; Nishida Y; Tsutsumida H; Goto M; Higashi M; Nomoto M; Yonezawa S
Br J Cancer; 2009 Jan; 100(2):344-51. PubMed ID: 19127263
[TBL] [Abstract][Full Text] [Related]
14. Heparanase expression is associated with histone modifications in glioblastoma.
Hong X; Nelson K; Lemke N; Kalkanis SN
Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
16. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
Walton TJ; Li G; Seth R; McArdle SE; Bishop MC; Rees RC
Prostate; 2008 Feb; 68(2):210-22. PubMed ID: 18092350
[TBL] [Abstract][Full Text] [Related]
17. MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer.
Yamada N; Hamada T; Goto M; Tsutsumida H; Higashi M; Nomoto M; Yonezawa S
Int J Cancer; 2006 Oct; 119(8):1850-7. PubMed ID: 16721789
[TBL] [Abstract][Full Text] [Related]
18. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.
Liu Y; Hong Y; Zhao Y; Ismail TM; Wong Y; Eu KW
Cancer Invest; 2008 Jul; 26(6):575-82. PubMed ID: 18584348
[TBL] [Abstract][Full Text] [Related]
19. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
[TBL] [Abstract][Full Text] [Related]
20. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos.
Saini M; Selokar NL; Agrawal H; Singla SK; Chauhan MS; Manik RS; Palta P
Reprod Fertil Dev; 2016 Apr; 28(6):824-37. PubMed ID: 25409339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
